Akero Therapeutics (AKRO) Earnings Date & Reports

A.I. Advisor

published Earnings

AKRO is expected to report earnings to rise 5.10% to -85 cents per share on November 13

Akero Therapeutics AKRO Stock Earnings Reports

Q3'24

Est.

$-0.85

Q2'24

Beat

by $0.02

Q1'24

Est.

$-0.90

Q4'23

Missed

by $0.16

Q3'23

Missed

by $0.01

The last earnings report on August 09 showed earnings per share of -81 cents, beating the estimate of -82 cents. With 661.18K shares outstanding, the current market capitalization sits at 1.96B.

View a ticker or compare two or three

Compare

AKRO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For AKRO
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for AKRO (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biotechnology company, which specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

601 Gateway Boulevard

Phone

+1 650 487-6488

Employees

Web

https://www.akerotx.com